| Dr Alexander Donald Shushan, MD | |
|
2000 Medical Pkwy, Suite 101, Annapolis, MD 21401-3742 | |
| (410) 268-8862 | |
| (410) 280-4701 |
| Full Name | Dr Alexander Donald Shushan |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 2000 Medical Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336315803 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Medical Group, Llc | 2860447315 | 431 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
Researchers from the Indiana University School of Medicine have studied the utility of making available a long acting reversible contraceptive for teenagers on the same day. They write that this small measure of making these contraceptives available on the same day could save the insurance providers a significant amount of money.
Two French physicists, Bernard Sapoval and Marcel Filoche from -cole Polytechnique in Palaiseau, France, suggest in a study published in EPJ E how evolution has shaped our lungs through successive optimisations of physical parameters such as conservation of energy and speed of delivery.
The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.
› Verified 5 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
Researchers from the Indiana University School of Medicine have studied the utility of making available a long acting reversible contraceptive for teenagers on the same day. They write that this small measure of making these contraceptives available on the same day could save the insurance providers a significant amount of money.
Two French physicists, Bernard Sapoval and Marcel Filoche from -cole Polytechnique in Palaiseau, France, suggest in a study published in EPJ E how evolution has shaped our lungs through successive optimisations of physical parameters such as conservation of energy and speed of delivery.
The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.
› Verified 5 days ago
| Entity Name | Orthopedic Physicians Of Annapolis Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780824615 PECOS PAC ID: 9032269154 Enrollment ID: O20090611000485 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
Researchers from the Indiana University School of Medicine have studied the utility of making available a long acting reversible contraceptive for teenagers on the same day. They write that this small measure of making these contraceptives available on the same day could save the insurance providers a significant amount of money.
Two French physicists, Bernard Sapoval and Marcel Filoche from -cole Polytechnique in Palaiseau, France, suggest in a study published in EPJ E how evolution has shaped our lungs through successive optimisations of physical parameters such as conservation of energy and speed of delivery.
The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander Donald Shushan, MD 201 Defense Hwy, Ste 100, Annapolis, MD 21401-8902 Ph: (667) 204-7000 | Dr Alexander Donald Shushan, MD 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401-3742 Ph: (410) 268-8862 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
Researchers from the Indiana University School of Medicine have studied the utility of making available a long acting reversible contraceptive for teenagers on the same day. They write that this small measure of making these contraceptives available on the same day could save the insurance providers a significant amount of money.
Two French physicists, Bernard Sapoval and Marcel Filoche from -cole Polytechnique in Palaiseau, France, suggest in a study published in EPJ E how evolution has shaped our lungs through successive optimisations of physical parameters such as conservation of energy and speed of delivery.
The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.
› Verified 5 days ago
Dr. Peter Norman Ove, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 | |
Garrett John Lynch, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Parkway, Suite 400, Annapolis, MD 21401 Phone: 410-573-2530 Fax: 410-573-2536 | |
Dr. Louis Joseph Ruland Iii, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2003 Medical Parkway, Suite 400, Annapolis, MD 21401 Phone: 410-573-2530 Fax: 410-573-2536 | |
Dr. Justin L Cashman Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 130 Admiral Cochrane Dr, Suite 303, Annapolis, MD 21401 Phone: 410-571-4338 Fax: 410-881-0159 | |
Dr. Marc F Brassard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 | |
Dr. Robert M Verklin Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 | |
Dr. James Macdonald, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 101, Annapolis, MD 21401 Phone: 410-268-8862 Fax: 410-280-4701 |